Table of Contents
Presented on June 3rd, 2022.
Each month biotechnology, pharmaceutical and academic partners, large and small, working on treatments and a cure for myotonic dystrophy will sit down with our community to share their progress and answer your questions. Click here to learn more about Arthex Biotech.
Dr. Beatriz Llamusi Troisi and Dr. Judy Walker present on Arthex Biotech’s lead investigational compound for myotonic dystrophy, ATX-01.
Click here to find all our upcoming Meet the DM Drug Developers dates.
